Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Apnea

1-methyl-3-isobutylxanthine has been researched along with Apnea in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Apnea: A transient absence of spontaneous respiration.

Research Excerpts

ExcerptRelevanceReference
"4."1.30cAMP-dependent reversal of opioid- and prostaglandin-mediated depression of the isolated respiratory network in newborn rats. ( Ballanyi, K; Hoch, B; Lalley, PM; Richter, DW, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballanyi, K1
Lalley, PM1
Hoch, B1
Richter, DW1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Apnea

ArticleYear
cAMP-dependent reversal of opioid- and prostaglandin-mediated depression of the isolated respiratory network in newborn rats.
    The Journal of physiology, 1997, Oct-01, Volume: 504 ( Pt 1)

    Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Animals; Animals, Newborn; Apnea; Cyclic AMP; GTP-Binding

1997